Alzamend Neuro, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
ALZN on Nasdaq
Industry
Pharmaceutical Preparations
Location
3500 Lenox Rd. Ne, Suite 1500, Atlanta, GA

Insiders trading volume in the past year

Alzamend Neuro, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Milton C. Ault III Director, 10%+ Owner $2.21M +$7.85K +0.36% Mar 21, 2025
Andrew H. Woo Director $102K Mar 15, 2022
Jeffrey Oram Director $102K Mar 15, 2022
Mark Gustafson Director $61.1K Mar 31, 2022
Stephan Jackman Chief Executive Officer, Director $46.3K Apr 28, 2023
William B. Horne Director $29.6K +$13K +78.8% Mar 26, 2025
David J. Katzoff Chief Financial Officer $5.59K +$5.05K +926% Mar 21, 2025
Lynne F. McGrath Director $3.44K Apr 30, 2024
Lien Escalona Chief Financial Officer Jun 14, 2021
Kenneth S. Cragun SVP of Finance Nov 30, 2022
Henry Carl Nisser Exec VP and General Counsel, Director Jun 14, 2021

Recent Insider Transactions by Companies or Individuals for Alzamend Neuro, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.